Telephone: 212.931.0704

In re Niaspan Antitrust Litigation, 2:13-md-2460-JD (E.D. Pa.)

We represent plaintiffs and direct purchasers of Niaspan in this class action alleging that brand and generic drug companies entered into an unlawful agreement to delay generic competition in the market for extended release niacin.  We are seeking to recover overcharges on behalf of the class of direct purchasers under the federal antitrust laws.  Plaintiffs prevailed against the defendants’ motion to dismiss the case, and are currently engaged in discovery.

Reach Out

Taus, Cebulash & Landau, LLP • 80 Maiden Lane • Suite 1204 • New York, NY 10038 • T: 212.931.0704 • E: